These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36633650)

  • 21. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
    Ruiz-Cordero R; Rao P; Li L; Qi Y; Atherton D; Peng B; Singh RR; Kim TB; Kawakami F; Routbort MJ; Alouch N; Chow CB; Tang X; Lu W; Brimo F; Matin SF; Wood CG; Tannir NM; Wistuba II; Chen K; Wang J; Medeiros LJ; Karam JA; Tamboli P; Sircar K
    Mod Pathol; 2019 Nov; 32(11):1698-1707. PubMed ID: 31231128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.
    Ginzburg S; Uzzo R; Al-Saleem T; Dulaimi E; Walton J; Corcoran A; Plimack E; Mehrazin R; Tomaszewski J; Viterbo R; Chen DY; Greenberg R; Smaldone M; Kutikov A
    J Urol; 2014 Feb; 191(2):296-300. PubMed ID: 23899990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
    Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
    BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.
    Liu S; Lee S; Rashid P; Bangash H; Hamid A; Lau J; Cohen R
    BJU Int; 2016 Oct; 118 Suppl 3():30-34. PubMed ID: 27457972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications.
    Patel AR; Lee BH; Campbell SC; Zhou M; Fergany AF
    Urology; 2011 Nov; 78(5):1095-9. PubMed ID: 21937095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of location and number of cores on the diagnostic accuracy of renal mass biopsy: an ex vivo study.
    Hobbs DJ; Zhou M; Campbell SC; Aydin H; Weight CJ; Lane BR
    World J Urol; 2013 Oct; 31(5):1159-64. PubMed ID: 22527673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.
    Salmasi A; Faiena I; Lenis AT; Pooli A; Johnson DC; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
    Urol Oncol; 2018 Dec; 36(12):527.e13-527.e19. PubMed ID: 30228094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database.
    Patel DN; Ghali F; Meagher MF; Javier-Desloges J; Patel SH; Soliman S; Hakimi K; Yuan J; Murphy J; Derweesh IH
    Urol Oncol; 2021 Jan; 39(1):79.e1-79.e8. PubMed ID: 33160847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of renal oncocytoma with synchronous contralateral renal cell carcinoma].
    Tsuji H; Kurita T; Tahara H; Negita M; Nagai N
    Hinyokika Kiyo; 2001 Jan; 47(1):27-9. PubMed ID: 11235217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
    Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
    Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary Approach and Outcomes of Pretreatment Small (cT1a) Renal Mass Biopsy: Single-Center Experience.
    Jiang P; Arada RB; Okhunov Z; Afyouni AS; Peta A; Brevik A; Xie L; Ayad M; Xu P; Morgan K; Tapiero S; Patel R; Nelson KJ; Lee JG; Clayman RV; Landman J
    J Endourol; 2022 May; 36(5):703-711. PubMed ID: 35018788
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma.
    Vijay V; Vokshi FH; Smigelski M; Nagpal S; Huang WC
    Clin Genitourin Cancer; 2023 Jun; 21(3):e114-e118. PubMed ID: 36535809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance.
    Alle N; Tan N; Huss J; Huang J; Pantuck A; Raman SS
    Abdom Radiol (NY); 2018 Jul; 43(7):1813-1819. PubMed ID: 29079986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal oncocytoma with synchronous contralateral renal cell carcinoma].
    Nishikawa K; Fujikawa S; Soga N; Wakita T; Arima K; Yanagawa M; Kawamura J
    Hinyokika Kiyo; 2002 Feb; 48(2):89-91. PubMed ID: 11968734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma.
    Dechet CB; Bostwick DG; Blute ML; Bryant SC; Zincke H
    J Urol; 1999 Jul; 162(1):40-2. PubMed ID: 10379735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncocytoma managed by active surveillance in a transplant allograft kidney: a case report.
    Pagano D; di Francesco F; Rosa L; Nwaiwu CA; Li Petri S; Gruttadauria S
    World J Surg Oncol; 2018 Jul; 16(1):123. PubMed ID: 29966524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
    Zhu B; Rohan SM; Lin X
    Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
    Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
    Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.